IKPM Stock Overview
Engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 2/6 |
Dividends | 1/6 |
PT Ikapharmindo Putramas Tbk Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | Rp258.00 |
52 Week High | Rp332.00 |
52 Week Low | Rp164.00 |
Beta | 0 |
11 Month Change | 19.44% |
3 Month Change | -17.31% |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 42.54% |
Recent News & Updates
Recent updates
Shareholder Returns
IKPM | ID Personal Products | ID Market | |
---|---|---|---|
7D | -3.0% | -2.1% | -1.2% |
1Y | n/a | 4.7% | 9.4% |
Return vs Industry: Insufficient data to determine how IKPM performed against the ID Personal Products industry.
Return vs Market: Insufficient data to determine how IKPM performed against the ID Market.
Price Volatility
IKPM volatility | |
---|---|
IKPM Average Weekly Movement | 9.5% |
Personal Products Industry Average Movement | 4.9% |
Market Average Movement | 5.8% |
10% most volatile stocks in ID Market | 12.8% |
10% least volatile stocks in ID Market | 2.9% |
Stable Share Price: IKPM's share price has been volatile over the past 3 months.
Volatility Over Time: IKPM's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of ID stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1978 | 1,035 | . Kartono | www.ikapharmindo.com |
PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in the areas of neurology, psychiatry, dermatology, nephrology, gastroenterology, cardiology, pulmonology, antibiotics, generics, and nutraceuticals; and over-the-counter drugs.
PT Ikapharmindo Putramas Tbk Fundamentals Summary
IKPM fundamental statistics | |
---|---|
Market cap | Rp438.01b |
Earnings (TTM) | Rp10.09b |
Revenue (TTM) | Rp429.89b |
43.1x
P/E Ratio1.0x
P/S RatioIs IKPM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IKPM income statement (TTM) | |
---|---|
Revenue | Rp429.89b |
Cost of Revenue | Rp242.95b |
Gross Profit | Rp186.94b |
Other Expenses | Rp176.84b |
Earnings | Rp10.09b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 5.99 |
Gross Margin | 43.48% |
Net Profit Margin | 2.35% |
Debt/Equity Ratio | 60.9% |
How did IKPM perform over the long term?
See historical performance and comparison